Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROPS
NCT00000585Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Aug 1983
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 3 trial of phenoxymethylpenicillin in pneumococcal infection, sponsored by National Heart, Lung, and Blood Institute. Started Aug 1983; status: completed.
02
Drugs
phenoxymethylpenicillin
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00000585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000585.